Literature DB >> 8392631

A mutation in VP4 defines a new step in the late stages of cell entry by poliovirus.

N Moscufo1, A G Yafal, A Rogove, J Hogle, M Chow.   

Abstract

During the entry of poliovirus into cells, a conformational transition occurs within the virion that is dependent upon its binding to the cell surface receptor. This conformational rearrangement generates an altered particle of 135S, results in the extrusion of capsid protein VP4 and the amino terminus of VP1 from the virion interior, and leads to the acquisition of membrane-binding properties by the 135S particle. Although the subsequent fate of VP4 is unknown, its apparent absence from purified 135S particles has long suggested that VP4 is not directly involved during virus entry. We report here the construction by site-specific mutagenesis of a nonviable VP4 mutant that upon transfection of the cDNA appears to form mature virus particles. These particles, upon interaction with the cellular receptor, undergo the 135S conformational transition but are defective at a subsequent stage in virus entry. The results demonstrate that the participation of VP4 is required during cell entry of poliovirus. In addition, these data indicate the existence of additional stages in the cell entry process beyond receptor binding and the transition to 135S particles. These post-135S stages must include the poorly understood processes by which nonenveloped viruses cross the cell membrane, uncoat, and deliver their genomes into the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392631      PMCID: PMC237900     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  Early interactions between poliovirus and ERK cells: some observations on the nature and significance of the rejected particles.

Authors:  M L FENWICK; P D COOPER
Journal:  Virology       Date:  1962-10       Impact factor: 3.616

2.  Early alteration of poliovirus in infected cells and its specific inhibition.

Authors:  K Lonberg-Holm; L B Gosser; J C Kauer
Journal:  J Gen Virol       Date:  1975-06       Impact factor: 3.891

3.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

4.  Myristoylation is important at multiple stages in poliovirus assembly.

Authors:  N Moscufo; J Simons; M Chow
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

5.  Studies on the in vitro uncoating of poliovirus. II. Characteristics of the membrane-modified particle.

Authors:  J De Sena; B Mandel
Journal:  Virology       Date:  1977-05-15       Impact factor: 3.616

6.  Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding.

Authors:  C E Fricks; J M Hogle
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

7.  Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily.

Authors:  C L Mendelsohn; E Wimmer; V R Racaniello
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

8.  Myristylation of picornavirus capsid protein VP4 and its structural significance.

Authors:  M Chow; J F Newman; D Filman; J M Hogle; D J Rowlands; F Brown
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

9.  The poliovirus receptor protein is produced both as membrane-bound and secreted forms.

Authors:  S Koike; H Horie; I Ise; A Okitsu; M Yoshida; N Iizuka; K Takeuchi; T Takegami; A Nomoto
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

10.  Infectious entry pathway of influenza virus in a canine kidney cell line.

Authors:  K S Matlin; H Reggio; A Helenius; K Simons
Journal:  J Cell Biol       Date:  1981-12       Impact factor: 10.539

View more
  28 in total

1.  Structure of the reovirus membrane-penetration protein, Mu1, in a complex with is protector protein, Sigma3.

Authors:  Susanne Liemann; Kartik Chandran; Timothy S Baker; Max L Nibert; Stephen C Harrison
Journal:  Cell       Date:  2002-01-25       Impact factor: 41.582

2.  Genome delivery and ion channel properties are altered in VP4 mutants of poliovirus.

Authors:  Pranav Danthi; Magdalena Tosteson; Qi-Han Li; Marie Chow
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

3.  Putative autocleavage of outer capsid protein micro1, allowing release of myristoylated peptide micro1N during particle uncoating, is critical for cell entry by reovirus.

Authors:  Amy L Odegard; Kartik Chandran; Xing Zhang; John S L Parker; Timothy S Baker; Max L Nibert
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

4.  Intramolecular and intermolecular uridylylation by poliovirus RNA-dependent RNA polymerase.

Authors:  Oliver C Richards; Jeannie F Spagnolo; John M Lyle; Susan E Vleck; Robert D Kuchta; Karla Kirkegaard
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

5.  Selective cleavage by trypsin of the capsid protein VP1 of type 3 poliovirus results in improved sorting of cell bound virions.

Authors:  L Piirainen; A Airaksinen; T Hovi; M Roivainen
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  Cold-adapted poliovirus mutants bypass a postentry replication block.

Authors:  A W Dove; V R Racaniello
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

7.  Single amino acid substitution of VP1 N17D or VP2 H145Y confers acid-resistant phenotype of type Asia1 foot-and-mouth disease virus.

Authors:  Haiwei Wang; Shanshan Song; Jianxiong Zeng; Guohui Zhou; Decheng Yang; Te Liang; Li Yu
Journal:  Virol Sin       Date:  2014-03-26       Impact factor: 4.327

8.  Molecular genetic analysis of revertants from a poliovirus mutant that is specifically adapted to the mouse spinal cord.

Authors:  Q Jia; J M Hogle; T Hashikawa; A Nomoto
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

9.  Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus.

Authors:  S Curry; E Fry; W Blakemore; R Abu-Ghazaleh; T Jackson; A King; S Lea; J Newman; D Stuart
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

10.  Mouse adaptation determinants of poliovirus type 1 enhance viral uncoating.

Authors:  T Couderc; F Delpeyroux; H Le Blay; B Blondel
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.